Drug intelligence / Profile preview

bifidobacterium animalis subsp. lactis Bb-12 + lactobacillus acidophilus La-5 + lactobacillus rhamnosus GG

Development stage
Unknown
Lead developer
Novonesis
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

A multi-strain probiotic combination consisting of *Bifidobacterium animalis subsp. lactis* BB-12, *Lactobacillus acidophilus* LA-5, and *Lactobacillus rhamnosus* GG. This live biotherapeutic product is designed to modulate the gut microbiota and systemic immune system. Clinical evidence from the ProPACT (Probiotics in the Prevention of Allergy among Children in Trondheim) trial indicates that maternal supplementation with this combination from late pregnancy through early breastfeeding significantly reduces the cumulative incidence of atopic dermatitis in offspring. The mechanism of action involves a reduction in the proportion of Th22 cells and a decrease in the expression of pro-inflammatory proteins such as CCL11 and IL-17C in the children.

Other names
LGG + Bb-12 + La-5ProPACT probiotic combination

Beyond the preview

Go deeper on bifidobacterium animalis subsp. lactis Bb-12 + lactobacillus acidophilus La-5 + lactobacillus rhamnosus GG.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bifidobacterium animalis subsp. lactis Bb-12 + lactobacillus acidophilus La-5 + lactobacillus rhamnosus GG.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call